DNA Origami and Structural Nanotechnology

Shanghai JiaoTong University leads the listed organizations with 195 documents in the 24-month window. The Chinese Academy of Sciences CAS follows with 169, while Ludwig Maximilians University of Munich has 112 and University of Sichuan has 109. Recent work spans responsive structures, delivery, sensing and measurement, rather than a single dominant application.

The field has received $139,362,287 across 179 grants since 2020. These figures describe grant activity, not company investment alone. The available funding data does not identify how much of the total went to each application or technical approach, so it cannot show which research direction received the largest share.

Amplifold announced a €5 million seed round in December 2025 for its DNA-origami rapid diagnostics work. This is a named company financing event in the available news, rather than a field-wide funding benchmark. The broader grant data records $139,362,287 across 179 grants since 2020, but does not provide a comparable breakdown by company or application.

Ludwig Maximilians University of Munich is the top listed patent holder, with 10 patents. Arizona Board Of Regents On Behalf Of Arizona State University holds 8, and Battelle Memorial Institute holds 7. The listed holders include universities and research organizations, reflecting the research-led character of much of the field’s patent activity.

No: patent activity declined 49.1% in the last 12 months compared with the previous 12 months. There were 163 patents in the 24-month window. By contrast, publications grew 6.3% in the last 12 months, indicating that recent research output has been more resilient than patenting activity.

DNA origami is an established research platform, but clinical translation remains early: the data records 17,855 publications and 3 clinical trials overall. Its strongest evidence is in design methods, sensing, measurement and materials research. Delivery studies are tackling stability and cellular uptake, while the small number of recorded trials highlights the distance between laboratory demonstrations and clinical use.

In September 2026, the University of Science and Technology of China and collaborators reported responsive locking in a topologically engineered DNA quadrilateral for biosensing. August 2026 work included a DNA-origami barrel for mRNA delivery from Tianjin University and the Chinese Academy of Sciences, and magnetic DNA-origami nanorotors. These results point to greater emphasis on responsive function and biological use.

Scaffolded origami folds a long DNA strand with shorter staples, while tile-based assembly and DNA bricks build structures from interacting units. Dynamic devices add controlled movement or switching; DNA-templated materials use DNA to position or grow other materials. The approaches trade off structural complexity, modularity, motion control and ease of producing consistent assemblies.

Biosensing and diagnostics account for 971 documents, while therapeutics and vaccines account for 1,062. Other listed applications include molecular measurement, nanoelectronics and fabrication, and synthetic cells and molecular transport. Recent examples include portable sensing, RNA delivery, protein measurement and DNA-templated metal growth, but performance and biological stability remain practical constraints.

China leads with 8,420 documents, followed by the United States with 7,423. Germany has 2,555 and the United Kingdom has 2,143. This distribution shows substantial activity across both Asian and North American research ecosystems, with European institutions also contributing strongly to research, patents and emerging applications.